Discussion about this post

User's avatar
Mike S's avatar

IIRC, the protocols for the HepB vax study included active monitoring for 4-5 days (a daily visit to or from a researcher) after every shot to proactively identify short term post injection events, as well as continuous passive monitoring, and final follow-up 3 months after the last vaccine dose which again IIRC was after the 4 month dose, ie at 7 months.

As you point out, a study of 3 doses of a vaccine over several months cannot possibly have only 5 days follow-up.

Lennie's avatar

I think this article confuses two very different questions: **Do safety studies exist? And were they sufficiently rigorous to establish safety, particularly in healthy newborns?**

Let's start with something important: Recombivax HB's pivotal trials did not use an inert placebo control. That matters. Without an appropriate inert-placebo comparison, how confidently can we distinguish adverse effects associated with vaccination from events that would have occurred anyway?

The prescribing information describes 434 doses administered to 147 healthy infants and children, with specified post-injection safety monitoring of five days after each dose.

The neonatal efficacy evidence is also important. The study involving 130 infants born to HepB-positive mothers used both hepatitis B immune globulin (HBIG) and vaccine, with historical controls. This does not provide the same evidentiary strength as a concurrent inert-placebo-controlled trial.

And dismissing autism concerns does not establish comprehensive vaccine safety. Nor does an antibody response establish the absolute clinical benefit for every newborn.

I'm not arguing that HepB vaccines have no benefits. Protecting babies born to mothers with hepatitis B is critically important.

But why should evidence supporting vaccination in that high-risk situation automatically settle the risk/benefit question for every healthy newborn, including those born to mothers who test negative?

**Where is the sufficiently rigorous evidence establishing the safety and individual risk/benefit of routine birth-dose vaccination in that low-risk population?**

Calling these questions propaganda doesn't answer them. Parents deserve the evidence, the limitations and the uncertainties before they consent.

Ready for more?